Autologous Bone Marrow Mononuclear Cells Reduce Therapeutic Intensity for Severe Traumatic Brain Injury in Children*
Pediatric Critical Care Medicine - United States
doi 10.1097/pcc.0000000000000324
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2015
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)